The IBN SINA Pharmaceutical Industry PLC — Company profile

Pharmaceutical Preparations · Bangladesh

Last price 293.2 BDT (At close: Oct 29, 2026) · Market cap 9.16B

Latest research: IBN SINA Pharmaceutical financial analysis: 18% 9M sales growth, Mawna plant capex and record 77% dividend (Oct 2026) · IBN SINA Pharmaceutical: 9M FY2026 sales up 18% as the Mawna plant lifts capital work-in-progress to BDT 4.1bn, funded mostly with debt

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Company profile

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflammatory, anti-dementia, anti-heamorrhoidal, anti-allergic-occular, anti-arthritis supplement, anti-asthmatic, anti-emetic, anti-fibrinolytic, anti-fungal, anti-glucoma, anti-histamine, anti-malarial, anti-melasma, anti-neuropathic, anti-protozoal, anti-spasmodic, anti-ulcerant, antibacterial, antibiotic, anticataract, anti-diabetic, anti-helmintic, antimigraine agent, antivertigo agent, and antiviral products. In addition, the company’s therapeutic products comprise antibiotic and steroid, gastrointestinal and skin diseas, antibiotic-occular, antifungal-occular, antiviral-occular, anxiolytic and antidepressant, aromatase inhibitor, bile acid, bisphosphonates, calcium supplement, cardiovascular preparation, corticosteroid, cough expectorant, dry eye syndrome, gastroprokinetic agent, haematinic/vitamin and mineral, hand rub, hormone products, intestinal anti-inflammatory, laxative, multivitamin and multi-minerals, muscle relaxant, mydriatic agents, nootropic, ORS, topical, urological preparation products. Further, it provides herbal and Unani products; and manufactures and trades in active pharmaceutical ingredients, natural medicines, polymer plastic bottles, plastic tubes, laminated tubes, and other related products. The company was incorporated in 1983 and is headquartered in Dhaka, Bangladesh.

Details

Key executives

Contact